|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.37 CAD | -1.53% |
|
-3.24% | -9.22% |
| 04-22 | BioSyent Inc.(TSXV:RX) dropped from S&P/TSX Venture Composite Index | CI |
| 04-01 | BioSyent To Present At LD Micro New York Investor Conference | MT |
BioSyent Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CAD 6.48 million compared to CAD 7.04 million a year ago. Net income was CAD 1.18 million compared to CAD 1.59 million a year ago.
Basic earnings per share from continuing operations was CAD 0.097 compared to CAD 0.127 a year ago. Diluted earnings per share from continuing operations was CAD 0.095 compared to CAD 0.125 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.22% | 71.16M | |
| +30.70% | 588B | |
| -3.42% | 364B | |
| +18.02% | 326B | |
| +4.27% | 285B | |
| +14.75% | 239B | |
| +9.80% | 210B | |
| -7.81% | 200B | |
| +8.12% | 167B | |
| -1.42% | 161B |
BIOSYENT INC. 
